HRTX
HERON THERAPEUTICS, INC. /DE/
Key Financials
Gross Profit
$113.6M
↑ 7.5%
Net Income
$-20195000
↓ 48.7%
Operating Income
$-2538000
↑ 78.0%
Total Liabilities
$241.5M
↓ 9.5%
Shareholders' Equity
$14.3M
↑ 142.6%
EPS (Diluted)
$-0.12
↓ 33.3%
Total Assets
$255.9M
↑ 9.7%
Cash & Equivalents
$28.6M
↑ 11.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | HRTX |
| Company Name | HERON THERAPEUTICS, INC. /DE/ |
| CIK | 818033 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 8582514400 |